Laura Damme - Feb 22, 2022 Form 4 Insider Report for TransMedics Group, Inc. (TMDX)

Role
VP, Clinical Affairs
Signature
By: /s/ Stephen Gordon, Attorney-in-Fact
Stock symbol
TMDX
Transactions as of
Feb 22, 2022
Transactions value $
$0
Form type
4
Date filed
2/24/2022, 04:48 PM
Next filing
Dec 16, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TMDX Stock Option (Right to Buy) Award $0 +38K $0.00 38K Feb 22, 2022 Common Stock 38K $13.28 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on February 22, 2026.